Geode Capital Management, LLC Celularity Inc Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.22 - $0.56 $22,214 - $56,544	100,973 Added 11.51%	978,106 $215,000
Q2 2023 Aug 11, 2023	SELL	$0.42 - $0.81 $118,439 - $228,419	-281,999 Reduced 24.33%	877,133 $464,000
Q1 2023 May 15, 2023	BUY	$0.56 - $1.15 $3,743 - $7,686	6,684 Added 0.58%	1,159,132 $718,000
Q4 2022 Feb 13, 2023	BUY	$1.08 - $2.35 $12,297 - $26,759	11,387 Added 1.0%	1,152,448 $1.49 Million
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $409,049 - $4.1 Million	951,277 Added 501.24%	1,141,061 $2.64 Million
Q2 2022 Aug 12, 2022	BUY	$2.81 - $12.91 $335,157 - $1.54 Million	119,273 Added 169.16%	189,784 $645,000
Q4 2021 Feb 11, 2022	BUY	$4.64 - $7.46 $18,360 - $29,519	3,957 Added 5.95%	70,511 $361,000
Q3 2021 Nov 12, 2021	BUY	$6.05 - $12.15 $402,651 - $808,631	66,554 New	66,554 $471,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.